Show
Sort by
-
SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021
-
- Journal Article
- A1
- open access
Dynamics of SARS-CoV-2 IgG in nursing home residents in Belgium throughout three BNT162b2 vaccination rounds : 19-month follow-up
-
- Journal Article
- A2
- open access
Professionals' treatment goals for long-term benzodiazepine and Z-drugs management : a qualitative study
-
- Journal Article
- A1
- open access
‘I haven’t discussed anything with anyone’ : lived experience of long-term users of benzodiazepine receptor agonists regarding their treatment for substance use disorder
-
- Journal Article
- A2
- open access
Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium
-
- Journal Article
- A1
- open access
Follow-up of SARS-CoV-2 antibody levels in Belgian nursing home residents and staff two, four and six months after primary course BNT162b2 vaccination
-
- Journal Article
- A1
- open access
From prescribing dilemma to knowledge in practice : the ontological politics of benzodiazepines and Z-drugs
-
- Journal Article
- A1
- open access
Validation of a rapid SARS-CoV-2 antibody test in general practice
-
- Journal Article
- A1
- open access
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign
-
- Journal Article
- A1
- open access
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium : a prospective cohort study with 12 months of follow-up